Human Serum Metabonomic Analysis Reveals Progression Axes for Glucose Intolerance and Insulin Resistance Statuses-Reference-Cited by-同舟云学术

Human Serum Metabonomic Analysis Reveals Progression Axes for Glucose Intolerance and Insulin Resistance Statuses

Published:2009-09-17 Issue:11 Volume:8 Page:5188-5195
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Zhang Xiuying¹,Wang Yulan¹,Hao Fuhua¹,Zhou Xianghai¹,Han Xueyao¹,Tang Huiru¹,Ji Linong¹

Affiliation:

1. Department of Endocrinology and Metabolism, Peking University People’s Hospital, Peking University Diabetes Centre, Beijing, China 100044, and State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Centre for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, The Chinese Academy of Sciences, Wuhan, China 430071

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr900524z

Reference48 articles.

1. Impaired Fasting Glucose and Impaired Glucose Tolerance

2. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine

3. A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Serotonin Transporter Absence on Brain Insulin Receptor Expression, Plasma Metabolome Changes, and ADHD-like Behavior in Mice fed a Western Diet;Biomolecules;2024-07-23

2. Advancements in metabolomics research in benign gallbladder diseases: A review;Medicine;2024-05-24

3. Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage;Endocrines;2024-04-19

4. Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making;American Journal of Nephrology;2024

5. Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs;Frontiers in Endocrinology;2023-10-31